Nautilus Biotechnology Inc Long-term Investment Intensity
Nautilus Biotechnology Inc long-term investment intensity. Nautilus Biotechnology Inc (NAUT) has a Long-term Investment Intensity of 27.6% as of June 2026. Long-term investments of $45.16 Million represent 27.6% of total assets of $163.58 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read Nautilus Biotechnology Inc (NAUT) total liabilities for a breakdown of total debt and financial obligations.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of Nautilus Biotechnology Inc (2021–2025)
Long-term investment intensity of Nautilus Biotechnology Inc from 2021 to 2025. This chart shows how Nautilus Biotechnology Inc's Long-term Investment Intensity has evolved across 5 annual periods from 2021 to 2025. As of June 2026, the intensity stands at 27.6%, reflecting long-term investments of $45.16 Million against total assets of $163.58 Million USD.
Nautilus Biotechnology Inc Long-term Investment Intensity by Year (2021–2025)
Nautilus Biotechnology Inc long-term investment intensity by year from 2021 to 2025. The table below presents the year-by-year Long-term Investment Intensity for Nautilus Biotechnology Inc from 2021 to 2025, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see balance sheet size of Nautilus Biotechnology Inc.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 27.6% | $52.74 Million | $191.11 Million | ▼ -3.9 pp |
| 2024 | 31.5% | $76.41 Million | $242.74 Million | ▲ +1.8 pp |
| 2023 | 29.7% | $90.65 Million | $305.56 Million | ▼ -7.2 pp |
| 2022 | 36.9% | $129.17 Million | $350.05 Million | ▲ +32.8 pp |
| 2021 | 4.1% | $16.37 Million | $398.45 Million | — |